Nanjing Hairong Pharmaceutical Technology

Nanjing Hairong Pharmaceutical Technology is a clinical-stage biopharmaceutical company headquartered in Nanjing, China, dedicated to the development of innovative drugs and high-end generic formulations. The company maintains a strategic focus on dermatology, ophthalmology, and pain management, leveraging a specialized technology platform for Vitamin D derivatives. Hairong has established a comprehensive value chain encompassing drug discovery, clinical development, and GMP-compliant manufacturing. Their portfolio includes both self-developed innovative candidates and complex generics designed to address significant unmet medical needs in the Chinese market. The company is listed on the National Equities Exchange and Quotations (NEEQ) and continues to expand its pipeline through internal R&D and strategic collaborations.